1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Renal cancer

Cabozantinib with nivolumab and ipilimumab for untreated intermediate- or poor-risk advanced renal cell carcinoma [ID6330]

In development [GID-TA11433] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 27428-Cabozantinib-in-Combination-with-Nivolumab-and-Ipilimumab-for-Renal-Cell-Carcinoma-V1.0-MAY2023-NON-CONF.pdf (nihr.ac.uk)